This finding has been confirmed by Hong et al.49, who examined the mRNA levels of BDNF and the mitogen-activated protein kinase 1/2 (MEK1/2), an immediate activator of the MEK–ERK pathway mediated by BDNF, in the leukocytes of MDD patients and healthy controls. The gene discussed is BDNF; the disease is major depressive disorder.